Cargando…

Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients

Chagas disease cardiomyopathy (CCC) is an inflammatory dilated cardiomyopathy occurring in 30% of the 6 million infected with the protozoan Trypanosoma cruzi in Latin America. Survival is significantly lower in CCC than ischemic (IC) and idiopathic dilated cardiomyopathy (DCM). Previous studies disc...

Descripción completa

Detalles Bibliográficos
Autores principales: Teixeira, Priscila Camillo, Ducret, Axel, Langen, Hanno, Nogoceke, Everson, Santos, Ronaldo Honorato Barros, Silva Nunes, João Paulo, Benvenuti, Luiz, Levy, Debora, Bydlowski, Sergio Paulo, Bocchi, Edimar Alcides, Kuramoto Takara, Andréia, Fiorelli, Alfredo Inácio, Stolf, Noedir Antonio, Pomeranzeff, Pablo, Chevillard, Christophe, Kalil, Jorge, Cunha-Neto, Edecio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633876/
https://www.ncbi.nlm.nih.gov/pubmed/34867990
http://dx.doi.org/10.3389/fimmu.2021.755782
_version_ 1784608018026987520
author Teixeira, Priscila Camillo
Ducret, Axel
Langen, Hanno
Nogoceke, Everson
Santos, Ronaldo Honorato Barros
Silva Nunes, João Paulo
Benvenuti, Luiz
Levy, Debora
Bydlowski, Sergio Paulo
Bocchi, Edimar Alcides
Kuramoto Takara, Andréia
Fiorelli, Alfredo Inácio
Stolf, Noedir Antonio
Pomeranzeff, Pablo
Chevillard, Christophe
Kalil, Jorge
Cunha-Neto, Edecio
author_facet Teixeira, Priscila Camillo
Ducret, Axel
Langen, Hanno
Nogoceke, Everson
Santos, Ronaldo Honorato Barros
Silva Nunes, João Paulo
Benvenuti, Luiz
Levy, Debora
Bydlowski, Sergio Paulo
Bocchi, Edimar Alcides
Kuramoto Takara, Andréia
Fiorelli, Alfredo Inácio
Stolf, Noedir Antonio
Pomeranzeff, Pablo
Chevillard, Christophe
Kalil, Jorge
Cunha-Neto, Edecio
author_sort Teixeira, Priscila Camillo
collection PubMed
description Chagas disease cardiomyopathy (CCC) is an inflammatory dilated cardiomyopathy occurring in 30% of the 6 million infected with the protozoan Trypanosoma cruzi in Latin America. Survival is significantly lower in CCC than ischemic (IC) and idiopathic dilated cardiomyopathy (DCM). Previous studies disclosed a selective decrease in mitochondrial ATP synthase alpha expression and creatine kinase activity in CCC myocardium as compared to IDC and IC, as well as decreased in vivo myocardial ATP production. Aiming to identify additional constraints in energy metabolism specific to CCC, we performed a proteomic study in myocardial tissue samples from CCC, IC and DCM obtained at transplantation, in comparison with control myocardial tissue samples from organ donors. Left ventricle free wall myocardial samples were subject to two-dimensional electrophoresis with fluorescent labeling (2D-DIGE) and protein identification by mass spectrometry. We found altered expression of proteins related to mitochondrial energy metabolism, cardiac remodeling, and oxidative stress in the 3 patient groups. Pathways analysis of proteins differentially expressed in CCC disclosed mitochondrial dysfunction, fatty acid metabolism and transmembrane potential of mitochondria. CCC patients’ myocardium displayed reduced expression of 22 mitochondrial proteins belonging to energy metabolism pathways, as compared to 17 in DCM and 3 in IC. Significantly, 6 beta-oxidation enzymes were reduced in CCC, while only 2 of them were down-regulated in DCM and 1 in IC. We also observed that the cytokine IFN-gamma, previously described with increased levels in CCC, reduces mitochondrial membrane potential in cardiomyocytes. Results suggest a major reduction of mitochondrial energy metabolism and mitochondrial dysfunction in CCC myocardium which may be in part linked to IFN-gamma. This may partially explain the worse prognosis of CCC as compared to DCM or IC.
format Online
Article
Text
id pubmed-8633876
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86338762021-12-02 Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients Teixeira, Priscila Camillo Ducret, Axel Langen, Hanno Nogoceke, Everson Santos, Ronaldo Honorato Barros Silva Nunes, João Paulo Benvenuti, Luiz Levy, Debora Bydlowski, Sergio Paulo Bocchi, Edimar Alcides Kuramoto Takara, Andréia Fiorelli, Alfredo Inácio Stolf, Noedir Antonio Pomeranzeff, Pablo Chevillard, Christophe Kalil, Jorge Cunha-Neto, Edecio Front Immunol Immunology Chagas disease cardiomyopathy (CCC) is an inflammatory dilated cardiomyopathy occurring in 30% of the 6 million infected with the protozoan Trypanosoma cruzi in Latin America. Survival is significantly lower in CCC than ischemic (IC) and idiopathic dilated cardiomyopathy (DCM). Previous studies disclosed a selective decrease in mitochondrial ATP synthase alpha expression and creatine kinase activity in CCC myocardium as compared to IDC and IC, as well as decreased in vivo myocardial ATP production. Aiming to identify additional constraints in energy metabolism specific to CCC, we performed a proteomic study in myocardial tissue samples from CCC, IC and DCM obtained at transplantation, in comparison with control myocardial tissue samples from organ donors. Left ventricle free wall myocardial samples were subject to two-dimensional electrophoresis with fluorescent labeling (2D-DIGE) and protein identification by mass spectrometry. We found altered expression of proteins related to mitochondrial energy metabolism, cardiac remodeling, and oxidative stress in the 3 patient groups. Pathways analysis of proteins differentially expressed in CCC disclosed mitochondrial dysfunction, fatty acid metabolism and transmembrane potential of mitochondria. CCC patients’ myocardium displayed reduced expression of 22 mitochondrial proteins belonging to energy metabolism pathways, as compared to 17 in DCM and 3 in IC. Significantly, 6 beta-oxidation enzymes were reduced in CCC, while only 2 of them were down-regulated in DCM and 1 in IC. We also observed that the cytokine IFN-gamma, previously described with increased levels in CCC, reduces mitochondrial membrane potential in cardiomyocytes. Results suggest a major reduction of mitochondrial energy metabolism and mitochondrial dysfunction in CCC myocardium which may be in part linked to IFN-gamma. This may partially explain the worse prognosis of CCC as compared to DCM or IC. Frontiers Media S.A. 2021-11-12 /pmc/articles/PMC8633876/ /pubmed/34867990 http://dx.doi.org/10.3389/fimmu.2021.755782 Text en Copyright © 2021 Teixeira, Ducret, Langen, Nogoceke, Santos, Silva Nunes, Benvenuti, Levy, Bydlowski, Bocchi, Kuramoto Takara, Fiorelli, Stolf, Pomeranzeff, Chevillard, Kalil and Cunha-Neto https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Teixeira, Priscila Camillo
Ducret, Axel
Langen, Hanno
Nogoceke, Everson
Santos, Ronaldo Honorato Barros
Silva Nunes, João Paulo
Benvenuti, Luiz
Levy, Debora
Bydlowski, Sergio Paulo
Bocchi, Edimar Alcides
Kuramoto Takara, Andréia
Fiorelli, Alfredo Inácio
Stolf, Noedir Antonio
Pomeranzeff, Pablo
Chevillard, Christophe
Kalil, Jorge
Cunha-Neto, Edecio
Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
title Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
title_full Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
title_fullStr Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
title_full_unstemmed Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
title_short Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
title_sort impairment of multiple mitochondrial energy metabolism pathways in the heart of chagas disease cardiomyopathy patients
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633876/
https://www.ncbi.nlm.nih.gov/pubmed/34867990
http://dx.doi.org/10.3389/fimmu.2021.755782
work_keys_str_mv AT teixeirapriscilacamillo impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT ducretaxel impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT langenhanno impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT nogocekeeverson impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT santosronaldohonoratobarros impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT silvanunesjoaopaulo impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT benvenutiluiz impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT levydebora impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT bydlowskisergiopaulo impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT bocchiedimaralcides impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT kuramototakaraandreia impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT fiorellialfredoinacio impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT stolfnoedirantonio impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT pomeranzeffpablo impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT chevillardchristophe impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT kaliljorge impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients
AT cunhanetoedecio impairmentofmultiplemitochondrialenergymetabolismpathwaysintheheartofchagasdiseasecardiomyopathypatients